139 related articles for article (PubMed ID: 3914171)
1. [Preliminary results of the treatment of non-lymphoblastic leukemia and bone marrow dysplasia with small doses of cytosine arabinoside].
Brodzki LM
Acta Haematol Pol; 1985; 16(1-2):85-9. PubMed ID: 3914171
[No Abstract] [Full Text] [Related]
2. [Aplastic anemia which terminated in hypoplastic leukemia 10 years after diagnosis].
Nishii K; Katayama N; Komada F; Kageyama S; Hoshino K; Tsukada T; Nishikawa M; Kobayashi T; Minami N; Shirakawa S
Rinsho Ketsueki; 1990 Sep; 31(9):1523-6. PubMed ID: 2174086
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary results of the treatment of various forms of non-lymphoblastic leukemia with small doses of cytosine arabinoside].
Brodzki LM; Pawelski S; Gepner-Woźniewska M
Pol Tyg Lek; 1986 Oct; 41(43):1376-9. PubMed ID: 3469629
[No Abstract] [Full Text] [Related]
4. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
5. [Low dose Ara-C for remission induction in aged patients with atypical nonlymphocytic leukemia and refractory anemia with excess blasts].
Sawada H; Yamagishi M; Mochizuki T; Ishikura H; Izumi Y; Park YH; Wano M; Usui T; Uchino H
Rinsho Ketsueki; 1983 Nov; 24(11):1464-72. PubMed ID: 6584648
[No Abstract] [Full Text] [Related]
6. [Results of the treatment of non-lymphoblastic leukemia with small doses of cytosine arabinoside].
Brodzki LM; Pawelski S; Gepner-Woźniewska M
Pol Tyg Lek; 1988 Mar; 43(11):355-8. PubMed ID: 3045770
[No Abstract] [Full Text] [Related]
7. [Differentiation inducing factor of leukemia cells and antineoplastic agents].
Hozumi M
Nihon Rinsho; 1982; 40(8):1865-71. PubMed ID: 6755002
[No Abstract] [Full Text] [Related]
8. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
[No Abstract] [Full Text] [Related]
9. [Small-dose cytarabine (Ara-C) in the treatment of myelodysplastic syndrome].
Dan K; Ogata K; Gomi S; Ohki I; Kuwabara T; Horikoshi H; Nomura T
Rinsho Ketsueki; 1984 Oct; 25(10):1600-5. PubMed ID: 6596446
[No Abstract] [Full Text] [Related]
10. CFU-E and CFU-C in various hematological disorders.
Mizoguchi H; Kubota K; Miura Y; Suzuki C; Takaku F
Haematologica; 1978 Aug; 63(4):444-53. PubMed ID: 100388
[No Abstract] [Full Text] [Related]
11. Partial purification and initial characterization of a novel differentiation factor for mouse myeloid leukemia cells.
Nakaya K; Kumakawa N; Nakamura Y
Biochem Int; 1985 Apr; 10(4):619-26. PubMed ID: 3861183
[TBL] [Abstract][Full Text] [Related]
12. [Differentiation induction of leukemic cells in acute myeloid leukemia].
Suzuki K; Yokoyama S; Asano Y; Tomoyasu S; Tsuruoka N; Hozumi M
Rinsho Ketsueki; 1984 Feb; 25(2):241-5. PubMed ID: 6590884
[No Abstract] [Full Text] [Related]
13. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
Brincker H
Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
[No Abstract] [Full Text] [Related]
14. [The effect of leukemia-inhibitory factor on the hematopoiesis and stromal precursor cells in long-term culture of murine bone marrow].
Drize NI; Gan OI; Chertkov IL; Goddar A; Jaques J
Biull Eksp Biol Med; 1996 Sep; 122(9):325-8. PubMed ID: 8974492
[No Abstract] [Full Text] [Related]
15. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
16. [Abnormalities of the erythropoiesis at the beginning of remission in acute promyelocytic leukemia treated with arabinoside-cytosine].
Dubois-Ferrière H; Aguercif M; Hazeghi P; Rudhardt M
Schweiz Med Wochenschr; 1970 Feb; 100(7):321-3. PubMed ID: 5263342
[No Abstract] [Full Text] [Related]
17. [Small doses of ARA-C in the treatment of myeloblastic leukemia and blast crisis of myelocytic leukemia].
Górski J; Kicińska M; Cenian E
Acta Haematol Pol; 1984; 15(3-4):167-70. PubMed ID: 6598941
[No Abstract] [Full Text] [Related]
18. [Reduced dosage of cytosine arabinoside in the treatment of acute myelocytic leukemia. Apropos of 3 cases].
Andrey C; Beris P; Plancherel C; de Loes S; Maurice P; Chapuis B
Schweiz Med Wochenschr; 1983 Jul; 113(27-28):980-4. PubMed ID: 6577584
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of stromal elements from human bone marrow cells to cytosine arabinoside in vitro.
Elstner E; Goldschmidt H; Wächter M; Ihle R
Haematol Blood Transfus; 1987; 31():177-80. PubMed ID: 3481752
[No Abstract] [Full Text] [Related]
20. [Preleukemic syndrome].
Kicińska Z; Paprocka E
Pol Tyg Lek; 1980 Feb; 35(8):287-9. PubMed ID: 6987636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
